EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear and consensual international recommendations on RA treatment are not available. In this paper recommendations for the treatment of RA with synthetic and biological disease-modifying antirheumatic drugs (DMAR...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Smolen, Josef S, Landewé, Robert, Breedveld, Ferdinand C, Dougados, Maxime, Emery, Paul, Gaujoux-Viala, Cecile, Gorter, Simone, Knevel, Rachel, Nam, Jackie, Schoels, Monika, Aletaha, Daniel, Buch, Maya, Gossec, Laure, Huizinga, Tom, Bijlsma, Johannes W J W, Burmester, Gerd, Combe, Bernard, Cutolo, Maurizio, Gabay, Cem, Gomez-Reino, Juan, Kouloumas, Marios, Kvien, Tore K, Martin-Mola, Emilio, McInnes, Iain, Pavelka, Karel, van Riel, Piet, Scholte, Marieke, Scott, David L, Sokka, Tuulikki, Valesini, Guido, van Vollenhoven, Ronald, Winthrop, Kevin L, Wong, John, Zink, Angela, van der Heijde, Désirée
Fformat: Texto
Iaith:English
Cyhoeddwyd: BMJ Group 2010
Pynciau:
Recommendations
Mynediad Ar-lein:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935329/
https://www.ncbi.nlm.nih.gov/pubmed/20444750
http://dx.doi.org/10.1136/ard.2009.126532

Rhyngrwyd

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935329/
https://www.ncbi.nlm.nih.gov/pubmed/20444750
http://dx.doi.org/10.1136/ard.2009.126532

Eitemau Tebyg